(210) | Number of the EPO application | 16726999 |
(220) | Filing date of the EPO application | 2016.05.04 |
(80) | EPO patent specification publication (B) | EPB nr. 35/2020, 2020.08.26 |
(110) | EPO patent number | 3280725 |
(21) | Number of the application | e 2018 0153 |
(71) | Name(s) of applicant(s), code of the country | AMGEN INC., US; |
(72) | Name(s) of inventor(s), code of the country | BUTZ Eric Alan, US; THOMSON Christy Ann, CA; GAVIN Marc Alain, US; FOLTZ Ian Nevin, CA; XIA Dong, US; ALCORN Dina N., US; LIM Ai Ching, US; KETCHEM Randal Robert, US; MANCHULENKO Kathy, CA; SEKIROV Laura, CA; BERRY Kelly Ann, CA; DE IMUS Cyr Clovis Chua, US; AGRAWAL Neeraj Jagdish, US; KANNAN Gunasekaran, US; LI Li, US; |
(73) | Name(s) of owner(s), code of the country | AMGEN INC., US; |
(54) | Title of the invention | INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS |
(13) | Kind-of-document code | A1 |
(51) | International Patent Classification | C07K 14/55 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2018.04.30 |
(86) | International application | PCT/US2016/030843, 2016.05.04 |
(87) | International publication | WO 2016/164937, 2016.10.13 |